Showing results (1-10 of 165) with videos related to
Sort By:
Pageof 17
Current Opinion in HIV and AIDS|April 18, 2009
Variable adherence to prescribed dosing regimens for protease inhibitors: scope and outcomesTerrence F BlaschkeClinical Pharmacology and Therapeutics|May 20, 2009
Global challenges for clinical pharmacology in the developing worldT F BlaschkeClinical Pharmacokinetics|January 1, 1977
Protein binding and kinetics of drugs in liver diseasesT F BlaschkeAnnual Review of Pharmacology and Toxicology|January 1, 1997
Medication compliance as a feature in drug developmentH Kastrissios, T F BlaschkeSchweizerische Medizinische Wochenschrift|December 8, 1990
Semi-quantitative simulation for reasoning about physiological models of drug kinetics and effectsT D Leemann, T F BlaschkeThe Journal of Pharmacology and Experimental Therapeutics|March 1, 1986
Ketoconazole inhibits cyclosporine metabolism in vivo in miceJ E Anderson, T F BlaschkeClinical Pharmacokinetics|February 1, 1995
Clinical pharmacokinetics of rifabutinM H Skinner, T F BlaschkeClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1996
The clinical pharmacokinetics of rifabutinT F Blaschke, M H SkinnerClinical Pharmacokinetics|January 1, 1984
Effect of concentration-dependent binding to plasma proteins on the pharmacokinetics and pharmacodynamics of disopyramideK M Giacomini, T F BlaschkeInternational Journal of Obesity (2005)|February 16, 2005
New targets for PPARgamma in the vessel wall: implications for restenosisD Bruemmer, F Blaschke, R E LawPageof 17